Press release content from Accesswire. The AP news staff was not involved in its creation.
JNC Resources Signs Definitive Agreement with Southern Precious Metals Ltd.
March 2, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / March 2, 2021 / JNC Resources Inc. (CSE:JNC)(OTCBB:JNCCF)(FRA:5VH) (“JNC” or the “Company”) and Southern Precious Metals Limited (SPML) are pleased to announce the signing of the definitive agreement (replacing the LOI signed December 8th, 2020), in which JNC will acquire a 100% interest in SPML and their assets, the Malebo and Solomons properties in New South Wales (NSW) Australia. In signing this definitive agreement with SPML, JNC would like to specifically thank and welcome key shareholders Dr. Chris Wilson and Dr. Quinton Hennigh for all their hard work and diligence in reaching this agreement. We look forward to leaning on both Dr. Wilson and Dr. Hennigh for their experience and advice to further these premier properties.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
Medexus Pharmaceuticals IncMarch 1, 2021 GMT
TORONTO, CHICAGO and MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced its financial and operating results for the three and nine months ended December 31, 2020. All dollar amounts below are in Canadian dollars unless specified otherwise.
Third Quarter Fiscal 2021 Financial Highlights: The Company achieved record revenue of $31.5 million for the three-month period ended December 31, 2020, versus $16.2 million for the same period last year. As previously reported, the revenue for the period included approximately $3 million in IXINITY® revenues, which were originally expected to be realized in September 2020, but were instead realized in
A woman places a flower in a wreath to honor senior citizens who have died from COVID-19 at Kei-Ai Los Angeles Healthcare Center during a protest Thursday, Feb. 25, 2021,
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; .
Novavax, Inc.February 26, 2021 GMT
Agreement includes COVID-19 vaccine technology transfer to Takeda for local manufacturing and commercialization in Japan
Takeda doses first participant in immunogenicity and safety study to support local regulatory application
GAITHERSBURG, Md., Feb. 26, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced progress in its collaboration with Takeda Pharmaceutical Company Limited, originally announced in August. The companies have signed an exclusive license agreement for Takeda’s development, manufacturing and commercialization of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate, in Japan. Additionally, Takeda dosed the first participants in
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Glory Star Enters Market for Intelligent IoT Terminals to Drive Development of Content Services
February 25, 2021 GMT
BEIJING, Feb. 25, 2021 /PRNewswire/ Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the “Company”), a leading mobile and online digital media and entertainment company in China, today announced that it has signed a content service agreement (the “Agreement”) with Hangzhou Beiying Network Technology Co., Ltd. (“Hangzhou Beiying”), a subsidiary of Dangbei Network Technology Co. Ltd. (“Dangbei Network”), the leading smart home entertainment solution developer and manufacturer. The Company has received the initial payment of RMB6 million from Hangzhou Beiying under the Agreement. The Company believes that the cooperation with Hangzhou Beiying will further catalyze the development of the Company’s content services business and t